Improving phase ii oncology trial using best observed RECIST response as an endpoint by modelling continuous tumour measurements

Eitemau Tebyg

• Improving phase II oncology trials using best observed RECIST response as an endpoint by modelling continuous tumour measurements
  gan: Lin, Chien‐Ju, et al.
  Cyhoeddwyd: (2017)
• Using continuous data on tumour measurements to improve inference in phase II cancer studies
  gan: Wason, James, et al.
  Cyhoeddwyd: (2013)
• Using continuous data on tumour measurements to improve inference in phase II cancer studies
  gan: Wason, James MS, et al.
  Cyhoeddwyd: (2013)
• Evaluating Continuous Tumor Measurement-Based Metrics as Phase II Endpoints for Predicting Overall Survival
  gan: An, Ming-Wen, et al.
  Cyhoeddwyd: (2015)
• Efficient analysis of time-to-event endpoints when the event involves a continuous variable crossing a threshold
  gan: Lin, Chien-Ju, et al.
  Cyhoeddwyd: (2020)